C9029 HCPCS Level II code: Injection, guselkumab, 1 mg
CMS terminated C9029: its last date of service was Dec 31, 2018. It stays here for looking up older claims; newer services need a current code.
Official description
C9029Injection, guselkumab, 1 mg
Short description: Injection, guselkumab
HCPCS · United States
Medicare details
The indicators CMS publishes with C9029 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- Type of service
- Other medical items or services; Ambulatory surgical center (facility usage for surgical services)
- BETOS category
- Other drugs
- Coverage statute
- 1833(t)
- Cross-reference
- See J1628
- Added
- Jan 1, 2018
- Terminated after
- Dec 31, 2018
Where C9029 sits
- 1C codesOutpatient prospective payment system
- 2Terminated C9029Injection, guselkumab, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code C9029 still valid?
No. CMS terminated C9029; its last date of service was Dec 31, 2018. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover C9029?
CMS lists C9029’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C9029
All C codesC9023Injection, testosterone undecanoate, 1 mgC9024Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabineC9025Injection, ramucirumab, 5 mgC9026Injection, vedolizumab, 1 mgC9027Injection, pembrolizumab, 1 mgC9028Injection, inotuzumab ozogamicin, 0.1 mgC9030Injection, copanlisib, 1 mgC9031Lutetium lu 177, dotatate, therapeutic, 1 mciC9032Injection, voretigene neparvovec-rzyl, 1 billion vector genomeC9033Injection, fosnetupitant 235 mg and palonosetron 0.25 mgC9034Injection, dexamethasone 9%, intraocular, 1 mcgC9035Injection, aripiprazole lauroxil (aristada initio), 1 mg